A Journey of Dietary Therapies for Epilepsy in Iran: Diet Restriction in the Ancient Era to the Ketogenic Diet in the Modern Period
Iranian Journal of Child Neurology,
Vol. 13 No. 3 (2019),
2 June 2019
Epilepsy, in children, is a common neurological problem which causes referral to child neurology clinics.
The prevalence of nonfebrile seizure in children (under 10 years old),is estimated from 5.2 to 8.1 per 1000. Also, the prevalence of epilepsy in Iran estimated about 5 %; it means 4 million people of Iranian population live with epilepsy in Iran.
Although antiseizure drugs (ASDs) are the essential treatment modalities in most children, more than 30% of epileptic children have intractable seizures or they suffer from drug adverse effects secondary to these medications.
Because only a limited number of epileptic patients benefit from surgical therapy using the additional therapeutic options is inevitable.
There are many available nonpharmacologic proven therapies for refractory seizures that Dietary therapy ( Ketogenic Diet) is one of the important therapeutic options in this group.
In this review, we will discuss the different features of pediatric epilepsy dietary therapies (Especially the Ketogenic Diet) in Iran and also the history of epilepsy in ancient Iran, utilization, effectiveness, side effects, tolerability, and acceptability as well as ongoing and future programs.
- Ketogenic Diet
- Diet Restriction
How to Cite
Koul R, Razdan S, Motta A. Prevalence and Pattern of Epilepsy (Lath/Mirgi/Laran) in Rural Kashmir, India. Epilepsia 1988; 29(2):116-122.
Schuele SU, Lüders HO. Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 2008; 7: 514–24.
Engel J Jr. Epilepsy in the world today: the medical point of view. Epilepsia 2002; 43(Suppl.6):12–13.
Singh A, Trevick S.The Epidemiology of Global Epilepsy. Neurol Clin 2016;34: 837–47.
Brundtland GH. Welcome: the WHO view and launch of the second phase of the Global Campaign Against Epilepsy. Epilepsia 2002; 43(Suppl. 6):5–6.
Pearl PL. Overview of Seizures and Epilepsy in Children. Swaiman KF, Ashwal S, Ferriero D, Schor NF, Finkel RS, Gropman AL, Pearl PL, Shevell MI(Eds). Swaiman’s Pediatric
Neurology: Principles and Practice. New York, 2017,e1207 e1211, Elsevier Inc.
Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural and treatment aspects. Epilepsia 1998; 29:36–54.
Sayemiri K, Tavan H, Sayemiri F, Mohammadi I, Carson KV. Prevalence of Epilepsy in Iran : A Meta-Analysis and Systematic Review. Iran J Child Neurol 2014 Autumn; 8(4):9-17.
Kwan P, Arzimanoglou A, Berg AT, BrodieMJ, Hauser WA, Mathern A, Moshe SL, Perucca E, Wiebe S, French J.Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069–77.
Urquhart J. Letter, How Islam changed medicine. Ibn Sina (Avicenna) saw medicine and surgery as one. BMJ 2006; 332: 120.
Berg AT, Shinnar S, Levy SR, Testa FM, Smith– apaport S, Beckerman B. Early development of intractable epilepsy in children:A prospective study. NEUROLOGY 2001 June;56 (1):1445-52.
Aziz H, Guvener A, Akhtar SW, Hasan KZ.Comparative Epidemiology of Epilepsy in Pakistan and Turkey: Population-Based Studies Using Identical Protocols. Epilepsia 1997; 38(6):716-722.
Lee PR, Kossoff EH. Dietary treatments for epilepsy: Management guidelines for the general practitioner.Epilepsy & Behavior 2011; 21:115– 21.
Kossoff EH, Wang HS.Dietary Therapies for
epilepsy. Biomed J 2013;36:2-8.
Wheless JW.History and Origin of the Ketogenic Diet. Stafstrom C E, Rho JM. Epilepsy and the Ketogenic Diet: Clinical Implementation & the Scientific Basis (Nutrition and Health). Otowa, 2004,31-50,Humana Press Inc.
Eadie MJ, Bladin BF. A disease once called sacred. A history of the medical understanding of epilepsy. Eastleigh 2001, 17-20, John Libbey, ISBN 0‐86196‐607‐4.
Al-Habeeb TA. A Pilot study of faith healers’ 20 A journey of dietary therapies for epilepsy in Iran Iran J Child Neurol. Summer 2019 Vol. 13 No. 3 views on evil eye, jinn possession, and magicin the kingdom of Saudi Arabia. J Family Community Med 2003;10(3):31-38.
Wilson JV, Reynolds EH.Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy. Medical History 1990; 34(2):185–98.
Magiorkinis E, Sidiropoulou K, Diamantis A. Hallmarks in the History of Epilepsy: From Antiquity Till the Twentieth Century. Foyaca-Sibat H. Novel Aspects on Epilepsy.
Mohkam M. Medicine and Nephro-Urology in Ancient Iran. J Ped. Nephrology 2013 July;1(1):3-5.
Nayernouri T.A Brief History of Ancient Iranian Medicine. Archives of Iranian Medicine2015;18(8):549-50.
Rawilnson G (Ed.).The Histories Book 3: Thaleia (Herodotus’ Histories). Iowa. 2015,36- 37, Start Publishing.
Baloyannis SJ. Abstracts from the 2nd International Congress on Epilepsy, Brain and Mind, Prague, March 2012: Epilepsy, Art and History. Epilepsy & Behavior 2013; 28:303–32.
Nayernouri T. Asclepius, Caduceus, and Simurgh as medical symbols; part II. Simurgh. crch Iran Med. 2010; 13(3): 255-61.
Ebrahimnejad H. Religion and medicine in Iran: from relationship to dissociation. Hist Sci 2002 Mar;40(127 Pt 1):91-112.
Dols MW. The Origins of the Islamic Hospital: Myth and Reality. Bulletin of the History of Medicine 1987:61:367-90.
Najmabadi M. History of Medicine in Post- Islamic Iran .Tehran 1987,99-111, Tehran University Publications.
Azizi MH. History of ancient medicine in Iran. Gondishapur School of Medicine: the most important medical center in antiquity. Arch Iranian Med 2008; 11: 116–19.
Modanlou HD. Historical evidence for theorigin of teaching hospital, medicalschool and the rise of academic medicine .Journal of uerinatology 2011; 31: 236–
Brandenburg D.Avesta und Medizin. Ein literaturgeschichtlicher Beitrag zur Heilkunde im
lten Persien. Janus 1972;59(4):269-307.
Gorji A,Khalegi Ghadiri M. History of epilepsy in Medieval Iranian Medicine. Neuroscience and Biobehavioral Reviews 2001;25:455-61. 32. World Health Organization. Epilepsy in the WHO Eastern Mediterranean region: bridging the gap. Availableat:http://www.emro.who.int/dsaf/ dsa1039.pdf. 010 Accessed: January 23, 2011 33. Siraisi NG. In:Avicenna in Renaissance Italy: the Canon and medical teaching in Italian universities after 1500, , Princeton,1987,77–124. Princeton University Press.
Elgood C. A medical history of Persia and the eastern caliphate from the earliest times to the year 1932 A.D.London 1951, 205-209 and 173,Cambridge University Press.
Sebastian A. Dates in Medicine: A chronological record of medical progress over three millennia. New York 2000,The Parthenon publishing group.
Lee B L. “Rhazes: His career and his writings”. Seminars in Pediatric Infectious Diseases 2001;12 (3): 266–72.
Abu Bakr Mohammad Ibn Zakariya Razi,Al- Hawi. Tehran, 1999,129-53,Al-Hawi Pharma.
Lennox WG. Epilepsy and related disorders.
hoston, 1960, Brown and Little Company.
Vanzan A,Paladin F.Epilepsy andPersian Culture: An Overview. Epilepsia 1992;33(6):1057-64.
A journey of dietary therapies for epilepsy in Iran Iran J Child Neurol. Summer 2019 Vol. 13 No. 3
Khosravi Am, Khosravi AA. Sina traditional medicine. Tehran 1994,32 35,Mohammad Press.
Asadi-Pooya A A, Nikseresht A R, Yaghoubi E.Old Remedies for Epilepsy: Avicenna’s Medicine. Iran RedCrescent Med J 2012; 4(3):174-77.
Kossof EH, McGrogan AR. Worldwide use of ketogenic diet. Epilepsia 2005;46(2):280-89.
Wheless JW. History of the ketogenic diet. Epilepsia 2008; 49(8):3–5.
Karimzadeh P. Experience of the keto diet: An Iranian perspective. 6th Global Symposium on
Ketogenic Therapies for Neurological Disorders: Embracing Diversity, Global Implementation and Individualized Care.2018 October.
Wilder RM.The effect of ketonemia on the course of epilepsy. Mayo Clin Bull 1921;2:1.
Barborka CJ. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch Neurol Psychiatry 1930;23:904–14.
Ghofrani M. efficacy of the ketogenic diet on intractable epilepsy in children. a report of 215 cases[Abstract].brain dev 2002;24:394.
Mostaghimi Ghomi P,Ashraf zadeh F, Ghofrani M. Efficacy of ketogenic diet on intractable epilepsy in children : A report of 215 cases. Journal of Medical Council of Iran 2001;18(4):288-92.
Karimzadeh P, Tabarestani S, Mahvelati F, Tonekaboni SH, Ghofrani M. Intractable seizure disorders: efficacy of the classic ketogenic diet. Iran J Child Neurology 2009;3(1):15-20.
Mirjavadi AS, Tonekaboni SH , Ghazav MR, Azargashb E, Abdollah Gorji F, Ghofrani M. Efficacy of the ketogenic diet as a therapy forintractable epilepsy in children. Iran J Child Neurology 2010;4(2):27-34.
Zamani GR, Mohammadi M, Ashrafi MR, Karimi P , Mahmoudi M , Shervin Badv R ,Tavassoli AR , Azizi Malamiri R.The effects of classic ketogenic diet on serumlipid profile inchildren with refractory seizures. Acta Neurol Belg 2016; 116(4):529-34.
Rezaei Sh, Kavoosi M, Shervin Badv R ,Mohammadi M, Zamani GR, Ashrafi MR, Yekaninejad MS , Mahmoudi M. The Influence of Ketogenic Diet on Liver Function in Children and Adolescents with Intractable Epilepsy. J
Compr Ped 2017;8(3):e12609.
Alaei MR, Ghazavi MR, Mahvelati F,Karimzadeh P, Shiva MR, Tonekaboni SH.The effect of the ketogenic diet on the growth and biochemical parameters of the children with resistant epilepsy.Iran J Child Neurol 2010;3(4):41-44.
Barzegar MM, Ostad Rahimi AR, SlampourSh, Shahbazi Sh. The effect of ketogenic diet on pediatric intractable epilepsy.Med J TUMS 2010;31(2):15-20.
Ashrafi MR, Hosseini SA, Zamani GR, Mohammadi M, Karimi P , Mahmoudi M ,Tavassoli AR, Shervin Badv R ,Heidari M,Karimi P , Azizi Malamiri R.The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula-based powder. Acta Neurol Belg 2017; 117 ( 1 ): 175 – 82.
Tonekaboni SH, Mostaghimi P, Mirmiran P, Abbaskhanian A, Abdollah Gorji F, Ghofrani M,Azizi F .Efficacy of the Atkins diet as therapy for intractable epilepsy in children. Archives of Iranian Medicine 2010;13(6): 492-97.
Barzegar M, Irandoust P , E. Mameghani M. A modified atkins diet for intractable childhood epilepsy. Iran J Child Neurol 2010;4(3):15-20.
Zare M, Okhovat AA, Esmaillzadeh A, Mehvari J, Najafi MR, Saadatnia M. Modified
Atkins diet in adult with refractory epilepsy: 22 A journey of dietary therapies for epilepsy in Iran Iran J Child Neurol. Summer 2019 Vol. 13 No. 3 controlled randomized clinical trial. Iranian journal of Neurology 2017; 16(2): 72-77.
Karimzadeh P, Sedighi M, BeheshtiM,AzargashbA,Ghofrani M, Abdollahe-Gorgi F. Low Glycemic Index Treatment in pediatric refractory epilepsy:The first Middle East report.
seizure 2014; 23: 570–72.
Ghazavi A, Tonekaboni SH, Karimzadeh P, Nikibakhsh AA, Khajeh A, Fayyazi A. The Ketogenic and Atkins Diets Effect on Intractable Epilepsy: A Comparison. Iran J Child Neurol
Ghofrani M, Talebian A, Mostaghimi P .Comparison of effects of ketogenic diet and IVIg in treatment of childhood intractable epilepsy. Scientific Journal of Hamadan University of Medical Sciences 2002;19(1):5-8.
Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing
countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008; 49: 1491-503.
Murthy JM: Some problems and pitfalls in developing countries. Epilepsia 2003;44(1):38–42.
Bharucha NE, Carpio A, Gallo Diop A. Epidemiology of epilepsy in developing countries.
ngel P, Pedley T. Epilepsy: A Comprehensive Textbook. Philadelphia, 2008,89–101,Lippincott Williams & Wilkins.
Cowan LD. The epidemiology of the epilepsies in children. MRDD Research Reviews 2002; 8: 71–81.
Bell GS, Sander JW. CPD- Education and selfassessment. The epidemiology of epilepsy: the size of the problem. Seizure 2001; 10: 306–16.
Carpio A, Hauser A. Epilepsy in the Developing World. Current Neurology and Neuroscience Reports 2009;9:319–26.
Sander JW, Shorvon SD. Incidence and prevalence studies in epilepsy and their
methodological problems: a review. J Neurol Neurosurg Psychiatry 1987;50:829-39.
World Health Organization: Atlas: Epilepsy Care in the World. Geneva, 2005, World Health
Meyer AC,Dua T,Ma J,Saxena Sh,Birbeck J.Global disparities in the epilepsy treatment gap:
a systematic review. Bull World Health Organ 2010;88:260–66.
Perucca E.Treatment of epilepsy in DC. BMJ 007; 334:1175–76.
Noorbala AA, Faghihzadeh S, Kamali K, Bagheri Yazdi SA, Hajebi A, Mousavi MT,
akhondzadeh Sh, Faghihzadeh E, Nouri B.Mental Health Survey of the Iranian Adult Population in 2015. Arch Iran Med 2017; 20(3):128 – 34.
Mohammadi MR, Ghanizadeh A, Davidian H, Mohammadi M, Norouzian M. Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 2006; 15: 476—82.
Integrated Child Development Services Scheme (ICDS scheme). Department of Social Welfare, Ministry of Education Government of India. New Delhi, June 1978.
Schoenberg BS. Clinical neuroepidemiology in developing countries. Neuroepidemiology 1982;l:137-42.
World Health Organization. Research protocol for measuring the prevalence of neurological disorders in developing countries. Neurosciencesprogramme, Geneva, 1981.
Siddiqui F, Sultan T, Mustafa Sh, Siddiqui S, Ali Sh, Malik A, Sajjad Z, Barech S, Jooma R. epilepsy in pakistan: national guidelines forclinicians. PJNS 2015;10(3):45-62.
A journey of dietary therapies for epilepsy in Iran Iran J Child Neurol. Summer 2019 Vol. 13 No. 3
Wang WZ,Wu JZ,Wang DS,Dai XY,Yang B,Wang TP,Yuan CL,Scott RA,Prilipko LL,de Boer HM,Sander JW,The prevalence and treatment gap in epilepsy in China:An ILAE/IBE/ WHO study. Neurology 2003;60;1544-45.
Benamer HT, Grosset DG.A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 2009;50(10):2301–4.
Comfield P ,Comfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord 2015; 17 (2): 117-23.
Ngugi AK, Bottemley C, Kleinschmidt I et al.Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51: 883-90.
Ketogenic diet centers outside the USA:International ketogenic Diet Centers. https:// www.ilae.org/patient care/ketogenic-diets/ international-centers.
Ketogenic diet centers in the USA. http://www. myketocal.com/kdcenters.aspx.
Kessler SK,Neal EG, Camfield CS, Kossoff EH.Dietary therapies for epilepsy: Future research. Epilepsy & Behavior 2011;22: 17–22.
Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006;35:1-5.
Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA. Efficacy of the ketogenic diet as a treatment option for epilepsy: Meta-analysis. J child Neurol 2006;21:193-98.
Mak SC, Chi CS, Wan CJ. Clinical experience of ketogenic diet on children with refractory epilepsy. Acta Paediatr Taiwan 1999;40:97-100.
Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists.J Child Neurol 2009;24:979-88.
Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics 2000;105:46.
Kilaru, S., Bergqvist, A.G., 2007. Current
treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia 2007;48:1703—1707.
Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007; 36:281–92.
Hong AM, Hamdy RF, Turner Z, Kossoff EH. Infantile spasms treated with the ketogenic diet: Prospective single center experience in 104 consecutive infants. Epilepsia 2010;51:1403—7.
Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol 2008;7:500- 506.
Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment ofchildhood epilepsy. Epilepsia 2009;50:1109-17.
Kossoff EH, Turner Z, Bluml RM, Pyzik PL,Vining EP.Arandomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav 2007;10:432-436.
Seo JH, Lee YM, Lee JS, Kang HC, Kim HD.Efficacy and tolerability of the ketogenic diet according to lipid: nonlipid ratios--comparison of 3: 1 with 4:1 diet. Epilepsia 2007;48:801-805.
Levy RG, Cooper PN, Giri P, Weston J. Ketogenic diet and other dietary treatments for epilepsy. The Cochrane Library 2012.
Freeman JM, Vining EP, Pillas DJ, et al.: The efficacy of the ketogenic diet–1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102:1358–63. 99. Suo C, Liao J, Lu X, et al. Efficacy and safety24 A journey of dietary therapies for epilepsy in IranIran J Child Neurol. Summer 2019 Vol. 13 No. 3of the ketogenic diet in Chinese children. Seizure 2013;22:174-78.
Thiele EA: Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003, 44(Suppl 7):26–29.
Sharma S, Gulati S, Kalra V, Agarwala A, Kabra M. Seizure control and biochemical profile on the ketogenic diet in young children withrefractory epilepsy--Indian experience. Seizure 2009;18:446-49.
Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann Indian Acad Neurol 2014;17:253- 58.
Caraballo R, Vaccarezza M, Cersósimo R, et al. Long-term follow-up of the ketogenic diet for refractory epilepsy: Multicenter Argentinean experience in 216 pediatric patients. Seizure 2011;20:640-45.
Patel A, Pyzik PL, Turner Z, Rubenstein JE, Kossoff EH. Longterm outcomes of children treated with the ketogenic diet in the past. Epilepsia 2010;51:1277-82.
Marsh EB, Freeman JM, Kossoff EH, Vining EP, Rubenstein JE, Pyzik PL, et al. The outcome of children with intractable seizures: A 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. Epilepsia 2006;47:425-30.
Kang HC, Lee HS, You SJ, Kang DC, Ko TS, Kim HD. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 2007;48(1):182–86.
Kang HC,Kim HD. Diet therapy in refractory pediatric eilepsy: increased efficacy andtolerability. Epileptic Disord 2006; 8 (4): 309-16.
Yoon Mi Kim YM,vaidya VV, Khusainov T, Kim HD,Kim SH, Lee EJ, Lee YM, Lee JS, Kang HC.Various indications for a modified Atkins
diet in intractable childhood epilepsy. Brain & development 2012;34(7): 570-75.
Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomized controlled trial. Epilepsia 2013;54:481-81.
Pfeifer HH, Thiele EA. Low-glycemicindex treatment: aliberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005; 65:1810–12.
- Abstract Viewed: 166 times
- PDF Downloaded: 46 times